OSE Immunotherapeutics SA's total assets for Q2 2025 were €104.18M, a decrease of -15.96% from the previous quarter. FR:OSE total liabilities were €53.58M for the fiscal quarter, a -10.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.